Join
Live feed
·
PRReleasevia Quantisnow
Yumanity Therapeutics Inc. logo

Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta

ByQuantisnow·Wall Street's wire, on your screen.
YMTX· Yumanity Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track YMTX (Yumanity Therapeutics Inc.) and more on Quantisnow.